ADSK
54
4
EW
23
-2
EQT
65
11
FITB
59
3
EMC
56
-7
VRSN
50
-3
JNPR
49
4
SYY
57
3
KEY
53
12
WFC
71
2
FAST
42
-2
IBM
58
-4
MRK
43
-2
LUV
56
4
NOV
37
-2
AVGO
68
-2
PPL
65
3
PYPL
60
4
UPS
40
12
MPC
44
2
ADSK
54
4
EW
23
-2
EQT
65
11
FITB
59
3
EMC
56
-7
VRSN
50
-3
JNPR
49
4
SYY
57
3
KEY
53
12
WFC
71
2
FAST
42
-2
IBM
58
-4
MRK
43
-2
LUV
56
4
NOV
37
-2
AVGO
68
-2
PPL
65
3
PYPL
60
4
UPS
40
12
MPC
44
2
Financhill
Back

Zevra Therapeutics Stock Price Chart

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
41

ZVRA
Zevra Therapeutics

Last Price:
$9.02
Seasonality Move:
26.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow exec targets $1.3T marke

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
  • The current trend is moderately bullish and ZVRA is experiencing slight selling pressure.

Zevra Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 9.15 Sell
20-day SMA: 8.91 Buy
50-day SMA: 8.11 Buy
200-day SMA: 8.11 Buy
8-day EMA: 9.06 Sell
20-day EMA: 8.88 Buy
50-day EMA: 8.43 Buy
200-day EMA: 7.79 Buy

Zevra Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 57.2 Buy
Chaikin Money Flow: -166940 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.56 - 9.16) Buy
Bollinger Bands (100): (7.28 - 8.6) Buy

Zevra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Zevra Therapeutics Stock

Is Zevra Therapeutics Stock a Buy?

ZVRA Technical Analysis vs Fundamental Analysis

Sell
41
Zevra Therapeutics (ZVRA) is a Sell

Is Zevra Therapeutics a Buy or a Sell?

Zevra Therapeutics Stock Info

Market Cap:
494.3M
Price in USD:
9.04
Share Volume:
560K

Zevra Therapeutics 52-Week Range

52-Week High:
9.76
52-Week Low:
4.20
Sell
41
Zevra Therapeutics (ZVRA) is a Sell

Zevra Therapeutics Share Price Forecast

Is Zevra Therapeutics Stock a Buy?

  • Zevra Therapeutics share price is 9.04 while ZVRA 8-day exponential moving average is 9.06, which is a Sell signal.
  • The stock price of ZVRA is 9.04 while Zevra Therapeutics 20-day EMA is 8.88, which makes it a Buy.
  • Zevra Therapeutics 50-day exponential moving average is 8.43 while ZVRA share price is 9.04, making it a Buy technically.
  • ZVRA stock price is 9.04 and Zevra Therapeutics 200-day simple moving average is 7.79, creating a Buy signal.

Fundamental Analysis of Zevra Therapeutics

Is Zevra Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.20 per share, an increase this year of $3.02 per share, and a decrease next year of $0.45 per share.

Technical Analysis of Zevra Therapeutics

Should I short Zevra Therapeutics stock?

* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.